Remedium Lifecare Limited (BOM:539561)

Market Cap	395.14M
Revenue (ttm)	4.05B
Net Income (ttm)	21.29M
Shares Out	403.20M
EPS (ttm)	0.05
PE Ratio	19.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,163,340
Average Volume	17,777,193
Open	0.9300
Previous Close	0.9100
Day's Range	0.9100 - 0.9500
52-Week Range	0.8000 - 21.6700
Beta	1.50
RSI	26.86
Earnings Date	Aug 11, 2025

About Remedium Lifecare

Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, io...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2024, Remedium Lifecare's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.